跳至主要内容
临床试验/JPRN-UMIN000003498
JPRN-UMIN000003498已完成未知

A pilot study of L-asparaginase monotherapy for Epstein-Barr virus positive T or NK cell lymphoproliferative disease (Chronic active Epstein-Barr virus infection) - A pilot study of L-asparaginase monotherapy for EBV-T/NK-LPD (CAEBV)

Tokyo Medical and Dental University School of Medicine, Department of Hematology0 个研究点目标入组 5 人开始时间: 2010年4月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
14years-old 至 69years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Need for radiation more than 15 Gy including palliation at the time of registration (2)Uncontrollable hypertension (3)History of myocardial infarction or angina or cardiomyopathy (4)HBs antigen positive (5)Severe infection except EBV (6)Liver cirrhosis, either biopsy proven or clinically diagnose (7)Active double cancer: overlapping cancer or asynchronous cancer within 5 years. Carcinoma in situ, intramucosal cancers, and other equivalent lesions are not included for the active double cancer. (8)Women during pregnancy, lactation period or of childbearing potentials not using a reliable contraceptive method (9)Use of major tranquilizer, antidepressant, or antimanic (10)Severe psychosis

研究者

发起方
Tokyo Medical and Dental University School of Medicine, Department of Hematology

相似试验